22157.jpg
Global Viral Vector Partnering Deal Terms and Agreements Analysis Report & Directory 2023: Access to Over 400 Deals and Corresponding Documents Signed Since 2016
August 04, 2023 09:08 ET | Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Viral Vector Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global Viral...
Global Market for Gene Therapy
Global Gene Therapy Market Report 2023: Promising Gene Therapy Innovations for Treatment of Inherited Retinal Diseases
June 22, 2023 05:03 ET | Research and Markets
Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gene Therapy...
Genetic Technologies Ltd
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
May 23, 2023 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious...
22157.jpg
Global Gene Therapy Market Report 2023: Major Players Include Novartis, Bluebird Bio, Spark Therapeutics, Audentes Therapeutics and Voyager Therapeutics
April 06, 2023 05:13 ET | Research and Markets
Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
Global Gene Therapy Market
Gene Therapy Global Market Report 2023: Increasing Prevalence of Cancer Fuels Demand
February 16, 2023 08:53 ET | Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...
Cash Receipts
Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
January 30, 2023 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,” Company”, “GTG”), a global leader in guidance-driven genomics-based tests in health,...
22157.jpg
Paternity & Relationship Testing Services Global Market Report 2023: Booming Direct to Consumer Testing Sector Fuels Growth
January 24, 2023 08:58 ET | Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides 2023 to...
GENE logo.png
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
December 06, 2022 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health,...
22157.jpg
Global Paternity & Relationship Testing Services Market Report to 2027 - Players Include AlphaBiolabs, Bureau Veritas, Canadian DNA Services and Easy DNA
November 25, 2022 06:18 ET | Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides 2023 to...
GENE logo.png
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
November 10, 2022 08:00 ET | Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...